Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The entry "H3 histone, family 3C pseudogene" (ENSG00000270575) refers to a **pseudogene** of the histone H3 family, not a protein-coding gene or functional biomolecule. Pseudogenes like this are genetically related to protein-coding genes encoding **histone H3 variants**—core proteins in nucleosome structure and chromatin regulation—but are themselves defined as nonfunctional sequences, typically lacking the ability to be translated into active protein due to frameshifts, premature stop codons, or regulatory deficits[1][3]. While the H3 family of histones is critically involved in DNA packaging, chromatin structure, and the regulation of gene expression, **pseudogenes** such as H3F3C are not believed to perform these roles, and there is **no evidence to suggest this gene is a therapeutic target** or associated with drug interactions or biomarker use. Some reports note that a subset of histone pseudogenes may nevertheless be transcribed into RNA, but the vast majority are considered nonfunctional genomic relics and are generally not included in discussions of valid molecular targets[1][3]. This target should not be considered a **therapeutic target**. Its inclusion in a therapeutic or target database is likely an error or artifact of naming convention and gene annotation, as **pseudogenes do not produce a functional protein product, are not receptors, enzymes, or conventional targets**, and **have no confirmed biological or pharmacological relevance** in standard clinical or biomedical research contexts[3]. **Summary:** H3 histone, family 3C pseudogene (ENSG00000270575) is a nonfunctional, noncoding genetic element. It is not a therapeutic target, has no drug interactions, and should be considered an incorrect or irrelevant entry in the context of drug discovery or target annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on H3 histone, family 3C pseudogene.